The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Open accessAbstract
Recent studies suggest that nuclear factor κB-inducing kinase (NIK) is suppressed through constitutive proteasome-mediated degradation regulated by TRAF2, TRAF3 and cIAP1 or cIAP2. Here we demonstrated that the degradation of NIK occurs upon assembly of a regulatory complex through TRAF3 recruitment of NIK and TRAF2 recruitment of cIAP1 and cIAP2. In contrast to TRAF2 and TRAF3, cIAP1 and cIAP2 seem to play redundant roles in the degradation of NIK, as inhibition of both cIAPs was required for noncanonical NF-κB activation and increased survival and proliferation of primary B lymphocytes. Furthermore, the lethality of TRAF3 deficiency in mice could be rescued by a single NIK gene, highlighting the importance of tightly regulated NIK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,001
The two NF-κB activation pathways and their role in innate and adaptive immunity
Bonizzi, G., & Karin, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.03.008 · Cited by 2,535
MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1
Malinin, N. L., Boldin, M. P., Kovalenko, A. V., & Wallach, D. (1997) · Nature · doi:10.1038/385540a0 · Cited by 1,280
Rothe, M., Pan, M.-G., Henzel, W. J., Ayres, T. M., & V. Goeddel, D. (1995) · Cell · doi:10.1016/0092-8674(95)90149-3 · Cited by 1,253
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,053
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Iotsova, V., Caamaño, J., Loy, J., Yang, Y., Lewin, A., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
Claudio, E., Brown, K., Park, S., Wang, H., & Siebenlist, U. (2002) · Nature Immunology · doi:10.1038/ni842 · Cited by 693
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 656
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
Self-citationBeg, A. A., Sha, W. C., Bronson, R. T., & Baltimore, D. (1995) · Genes & Development · doi:10.1101/gad.9.22.2736 · Cited by 473
Liao, G., Zhang, M., Harhaj, E. W., & Sun, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403286200 · Cited by 465
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase
Shinkura, R., Kitada, K., Matsuda, F., Tashiro, K., Ikuta, K., Suzuki, M., Kogishi, K., Serikawa, T., & Honjo, T. (1999) · Nature Genetics · doi:10.1038/8780 · Cited by 450
CD40 regulates the processing of NF-kappaB2 p100 to p52
Coope, H. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf542 · Cited by 440
NF-κB and Rel Proteins in Innate Immunity
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60618-5 · Cited by 428
Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif
Saha, S. K., Pietras, E. M., He, J. Q., Kang, J. R., Liu, S., Oganesyan, G., Shahangian, A., Zarnegar, B., Shiba, T. L., Wang, Y., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601220 · Cited by 423
Self-citationDefective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice
Yin, L., Wu, L., Wesche, H., Arthur, C. D., White, J. M., Goeddel, D. V., & Schreiber, R. D. (2001) · Science · doi:10.1126/science.1058453 · Cited by 409
Dejardin, E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.007 · Cited by 344
Bonizzi, G., Bebien, M., Otero, D. C., Johnson‐Vroom, K. E., Cao, Y., Vu, D., Jegga, A. G., Aronow, B. J., Ghosh, G., Rickert, R. C., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600391 · Cited by 338
Bridging the Gap: Composition, Regulation, and Physiological Function of the IκB Kinase Complex
Zandi, E., & Karin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4547 · Cited by 321
Gardam, S., Sierro, F., Basten, A., Mackay, F., & Brink, R. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.009 · Cited by 248
Targeted Disruption of TRAF3 Leads to Postnatal Lethality and Defective T-Dependent Immune Responses
Xu, Y., Cheng, G., & Baltimore, D. (1996) · Immunity · doi:10.1016/s1074-7613(00)80497-5 · Cited by 243
Self-citationGaither, A., Porter, D., Yao, Y., Borawski, J., Yang, G., Donovan, J., Sage, D., Slisz, J., Tran, M., Straub, C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5173 · Cited by 224
Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex
Matsuzawa, A., Tseng, P.-H., Vallabhapurapu, S., Luo, J.-L., Zhang, W., Wang, H., Vignali, D. A. A., Gallagher, E., & Karin, M. (2008) · Science · doi:10.1126/science.1157340 · Cited by 217
Grech, A. P., Amesbury, M., Chan, T., Gardam, S., Basten, A., & Brink, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.011 · Cited by 216
Matsushima, A., Kaisho, T., Rennert, P. D., Nakano, H., Kurosawa, K., Uchida, D., Takeda, K., Akira, S., & Matsumoto, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.631 · Cited by 200
Inhibitor of Apoptosis Protein cIAP2 Is Essential for Lipopolysaccharide-Induced Macrophage Survival
Conte, D., Holcik, M., Lefebvre, C. A., LaCasse, E., Picketts, D. J., Wright, K. E., & Korneluk, R. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.699-708.2006 · Cited by 191
Self-citationPosttranscriptional Downregulation of c-IAP2 by the Ubiquitin Protein Ligase c-IAP1 In Vivo
Conze, D. B., Albert, L., Ferrick, D. A., Goeddel, D. V., Yeh, W.-C., Mak, T., & Ashwell, J. D. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3348-3356.2005 · Cited by 189
Self-citationControl of canonical NF-κB activation through the NIK–IKK complex pathway
Zarnegar, B., Yamazaki, S., He, J. Q., & Cheng, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707959105 · Cited by 183
Self-citationRescue of TRAF3-null mice by p100 NF-κB deficiency
He, J. Q., Zarnegar, B., Oganesyan, G., Saha, S. K., Yamazaki, S., Doyle, S. E., Dempsey, P. W., & Cheng, G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061166 · Cited by 165
Self-citationBrown, K. D., Hostager, B. S., & Bishop, G. A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.8.943 · Cited by 156
Specificity of TRAF3 in Its Negative Regulation of the Noncanonical NF-κB Pathway
He, J. Q., Saha, S. K., Kang, J. R., Zarnegar, B. J., & Cheng, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610271200 · Cited by 117
Self-citationRegulation of TRAF2 Signaling by Self-induced Degradation
Brown, K. D., Hostager, B. S., & Bishop, G. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111522200 · Cited by 105
TRAF3 Forms Heterotrimers with TRAF2 and Modulates Its Ability to Mediate NF-κB Activation
He, L., Grammer, A. C., Wu, X., & Lipsky, P. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407284200 · Cited by 82
BAFF costimulation of Toll‐like receptor‐activatedB‐1 cells
Ng, L. G., Ng, C., Woehl, B., Sutherland, A. P. R., Huo, J., Xu, S., Mackay, F., & Lam, K. (2006) · European Journal of Immunology · doi:10.1002/eji.200635956 · Cited by 82
Dadgostar, H., & Cheng, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24775 · Cited by 64
Self-citationDifferential Regulation of CD40-Mediated TNF Receptor-Associated Factor Degradation in B Lymphocytes
Moore, C. R., & Bishop, G. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3780 · Cited by 46
Holčı́k, M., Lefebvre, C. A., Hicks, K., & Korneluk, R. G. (2002) · BMC Genomics · doi:10.1186/1471-2164-3-5 · Cited by 44
Self-citationCutting-Edge Apoptosis-Based Therapeutics: A Panacea for Cancer?
Fischer, U., Janssen, K., & Schulze‐Osthoff, K. (2007) · BioDrugs · doi:10.2165/00063030-200721050-00001 · Cited by 29
Cited by
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00312-6 · Cited by 2,135
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
Metadata
- Authors
- Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T., Yang, X., Yeh, W.-C., Mak, T. W., Korneluk, R. G., & Cheng, G.
- Venue
- Nature Immunology
- Published
- 2008-11-09
- Volume
- 9
- Issue
- 12
- Pages
- 1371-1378
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1990089954
- Cited by
- 604
- References
- 42
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.